Grim Age, Grim Prognosis: Epigenetic Aging Predicts Pancreatic Surgery Risk [0.03%]
严峻的年龄，严峻的预后：表观遗传衰老预测胰腺手术风险
Sophie Kollbeck,Carsten Palnæs Hansen,Mikkel T Bonde et al.
Sophie Kollbeck et al.
Objective: To evaluate the association of Epigenetic age acceleration (EAA), measured using the Horvath, Pheno, and Grim clocks, with overall survival (OS), postoperative complications, and failure of adjuvant chemotherap...
U.S. Surgical Practice: 23-Year Trends in Medicare Procedures and Reimbursement [0.03%]
美国外科实践：医疗保险程序和补偿的23年趋势
Rohin Singh,Ataollah Shahbandi,Aman Singh et al.
Rohin Singh et al.
Objective: This study has two goals: first, to characterize the procedural utilization among the Medicare population for the top 10 most commonly performed procedures by the 11 largest surgical specialties from 2000 to 20...
International Validation of a Recurrence Risk Model for Stage II Colon Cancer: The SPHERE Study [0.03%]
国际二期结直肠癌复发风险预测模型验证研究（SPHERE研究）
Kohei Shigeta,Shodai Mizuno,Doruk Orgun et al.
Kohei Shigeta et al.
Objective: To validate the utility of recurrence prediction value (RPV) in identifying patients with UICC stage II colon cancer who would benefit from adjuvant chemotherapy (AC). ...
Two-stage Hepatectomy Versus Liver Transplantation for Patients with Marginally Resectable Extensive Bilobar Colorectal Liver Metastases [0.03%]
边缘可切除的广泛双侧结直肠肝转移患者二期肝切除术与肝脏移植的比较研究
Yosuke Nakao,René Adam,Abdul Halim Nasser et al.
Yosuke Nakao et al.
Objective: To compare outcomes following two-stage hepatectomy (TSH) or liver transplantation (LT) in patients with extensive bilobar colorectal liver metastases (CRLM). ...
Effect of Centralized Surgical Care on Performance Outcomes Across Multi-Hospital Systems: A Systematic Review [0.03%]
集中化外科护理对多院系统绩效结果影响的系统综述
Brett A Johnson,Anoosha Moturu,Shelby Eagle et al.
Brett A Johnson et al.
Objective: To evaluate the effect of centralized surgical care on clinical and operational performance across multi-hospital systems. Summary background d...
Timing of Curative Surgery in Postoperative Enterocutaneous Fistulas: A Retrospective Cohort Study of 200 patients [0.03%]
术后肠瘘患者限期手术的时机研究（200例回顾性队列研究）
Clément Pastier,Maxime K Collard,Alexandre Challine et al.
Clément Pastier et al.
Objective: To assess the distribution of National Institutes of Health (NIH)-funded surgeon-scientists by residency training institution and to examine whether training at institutions with higher NIH funding is associate...
The Efficacy and Safety of Intrapancreatic Bile Duct Resection Applied in Type I of Congenital Bile Duct Dilation: A Multi-center Control Cohort Study [0.03%]
I型先天性胆管扩张症胰内胆总管切除术疗效及安全性研究：多中心队列研究报告
Chang-Zhen Yang,Cheng-Zhan Zhu,Zhi-Yu Chen et al.
Chang-Zhen Yang et al.
Objective: To compare the efficacy and safety of radical extrahepatic cyst excision including the intrapancreatic bile duct (REC) and subtotal extrahepatic cyst excision preserving the intrapancreatic bile duct (SEC) in t...
Risk of Recurrent Hypoglycemia and Long-term Survival after total Pancreatectomy: A Prospective Observational Study [0.03%]
全胰腺切除术后低血糖复发风险及长期生存的前瞻性观察研究
Zofia Czarnecka,Kevin Verhoeff,Alice L J Carr et al.
Zofia Czarnecka et al.
Objective: To evaluate risk of severe hypoglycemia after total pancreatectomy (TP). Background: Historically, TP was feared due to loss...
Beyond P Values: Novel Minimal Important Difference of the Comprehensive Complication Index (CCI®) that reflects a Meaningful Outcome for Patients Undergoing Major Abdominal Surgery [0.03%]
置信度因子P值之外：综合并发症指数（CCI）的新型最小重要差异，该指数反映了接受腹部大手术患者的重要结果
Fariba Abbassi,Matthias Pfister,Julia Braun et al.
Fariba Abbassi et al.
Objective: To estimate the Minimal Important Difference (MID) of the Comprehensive Complication Index® (CCI®) in patients undergoing abdominal surgery. ...
Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial [0.03%]
新辅助治疗后（可切除）胰腺癌患者的手术并发症：PREOPANC-2 随机对照试验结果
Esther N Dekker,Rutger T Theijse,Jacob L van Dam et al.
Esther N Dekker et al.
Objective: To compare the incidence of major surgical complications between patients with (borderline) resectable pancreatic cancer treated with neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherap...